Email Alert | RSS    帮助

中国防痨杂志 ›› 2011, Vol. 33 ›› Issue (2): 103-108.

• 论著 • 上一篇    下一篇

耐多药肺结核患者合并呼吸道感染的菌种分布及药敏分析

郝晓晖 唐神结 陈先平 刘一典 乐军   

  1. 同济大学附属上海市肺科医院结核科,上海市结核(肺)重点实验室 上海 200433
  • 收稿日期:2010-06-06 出版日期:2011-02-20 发布日期:2012-01-19
  • 通信作者: 唐神结 E-mail:tangsj1106@sina.com
  • 基金资助:

    国家十一五重大专项课题“特大城市结核病综合防治模式研究”(2009ZX10003-017);上海市传染病公共卫生重点学科建设(08GWZX0104)

lysis of pathogens isolated from lower respiratory tract in patients with multidrug-resistant pulmonary tub

Hao Xiaohui,Tang Shenjie,Chen Xianping,Liu Yidian,Yue Jun   

  1. Department of tuberculosis, Shanghai Pulmonary Hospital Tongji University School of Medicine, Shanghai Key Laboratory of Tuberculosis, Shanghai 200433, China
  • Received:2010-06-06 Online:2011-02-20 Published:2012-01-19
  • Contact: Tang Shenjie E-mail:tangsj1106@sina.com

摘要: 目的 了解耐多药肺结核患者合并呼吸道感染病原菌分布及耐药情况,指导临床合理用药。 方法 选取上海市肺科医院2007年1月—2009年12月住院耐多药肺结核合并呼吸道感染痰菌培养阳性病例127例及同期住院初治肺结核合并呼吸道感染痰菌培养阳性病例432例进行痰培养细菌鉴定及药敏试验,并进行分析。 结果 127例耐多药肺结核合并下呼吸道感染病例共分离出菌株151株,其中,以革兰阴性杆菌居首位,占67.5%,其次为真菌占30.5%,革兰阳性球菌占2%。与初治肺结核合并下呼吸道感染菌群比较,耐多药组肺炎克雷伯菌、大肠埃希菌、阴沟肠杆菌、不动杆菌等耐药程度较高的机会致病菌比率明显高于初治组,而较为常见、耐药程度较低的致病菌副流感嗜血杆菌则明显低于初治组,2组差异有统计学意义(P<0.05)。耐多药组真菌感染率(30.5%)高于初治肺结核组(20.6%)(P<0.05),革兰阳性球菌感染比率低于初治肺结核组,2组差异有统计学意义(P<0.05),混合感染率增高(P<0.05)。药敏显示革兰阴性杆菌对第三代以上头孢菌素、碳青霉烯类、喹诺酮类抗生素较敏感,细菌耐药程度增加,两组间比较有统计学意义(P<0.05)。革兰阳性球菌对青霉素、克林霉素耐药率高,对万古霉素较敏感。 结论 耐多药肺结核患者合并呼吸道感染病原菌以革兰阴性机会致病菌为主,且耐药现象严重,真菌混合感染增加。临床应重视细菌培养及药敏试验,减少不合理用药,积极治疗合并症,减少混合感染。

关键词: 结核, 肺, 结核, 抗多种药物性, 呼吸道感染, 真菌, 细菌, 抗药性, 微生物

Abstract: Objective To investigate the distribution and drug resistance of pathogens in multidrug-resistant pulmonary tuberculosis patients with lower respiratory tract infection.  Methods From January 2007 to December 2009, 127 multidrug-resistant pulmonary tuberculosis patients with sputum culture-positive lower respiratory tract infection and 432 first medicina treatment of pulmonary tuberculosis patients with sputum culture-positive lower respiratory tract infection were examined for bacterial identification and susceptibility test, then analysis.  Results A total of 157 pathogenic bacteria strains were isolated from 127 cases of multidrug-resistant pulmonary tuberculosis with lower respiratory tract infection.Among them, Gram-negative bacillus was in the first place, accounting for 67.5%, followde by Fungi accounted for 30.5%, Gram-positive bacteria 2%. Compared with the first medicina treatment of pulmonary tuberculosis patients,ratioof opportunistic Gram-negative bacillus in patients with multidrug-resistant pulmonary tuberculosis, Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, Acinetobacter,was significantly higher.However, ratioof less resistant pathogens, Haemophilus parainfluenzae,in MDR patients was significantly lower than that of patients with the first medicina treatment of pulmonary tuberculosis,it was statistically significant difference between the two groups (P<0.05).Ratio of Fungal infection(30.5%) in patients with multidrug-resistant pulmonary tuberculosis is significantly higher than that of first medical treatment of pulmonary tuberculosis patients (20.6%)(P<0.05).Gram-positive cocci infection rate of MDR patients is lower than that of first medical treatment of pulmonary tuberculosis patients,it was statistically significant difference between the two groups (P<0.05). Mixed infection rate increased in MDR patients (P<0.05).Gram-negative bacteria susceptibility showed theThe third generation of the above cephalosporins, carbapenems, quinolones had more sensitive, the bacterial resistance level was incresed between the two groups (P<0.05). Gram-positive cocci to penicillin, clindamycin resistance rates was higher, more sensitive to vancomycin.  Conclusion The primary pathogenic bacteria was Gram-negative opportunistic pathogen in lowerrespiratory tract of the patients with lower infection MDR pulmonary tuberculosis,and drug resistance is serious, fungal infection and mixed infection rate increased. Clinical attention should be paid bacterial culture and sensitivity test, to reduce irrational drug use, aggressive treatment of complications, reduce the mixed infection.

Key words: tuberculosis,pulmonary, tuberculosis,multidrug-resistant, drug-resistance,multiple,bacterial